Aplastic anemia: Etiology, molecular pathogenesis, and emerging concepts

Area of Science:

• Hematology
• Immunology
• Genetics

Background:

• Aplastic anemia (AA) is a rare, potentially fatal bone marrow failure disorder.
• It is characterized by hypocellular bone marrow and peripheral cytopenias.
• The exact molecular pathogenesis remains incompletely understood.

Purpose of the Study:

• To provide a comprehensive review of the current understanding of aplastic anemia.
• To discuss the immunobiology and molecular pathogenesis of AA.
• To explore future directions in AA research and patient care.

Main Methods:

• Review of existing literature on aplastic anemia.
• Analysis of immunologic and genetic factors implicated in AA.
• Discussion of advancements in genomic sequencing and related techniques.

Main Results:

• Evidence suggests an antigen-driven, autoimmune T-cell mediated attack on hematopoietic stem cells.
• Genetic factors including mutations in TERT, TERC, BCOR/BCORL, PIGA, DNMT3A, ASXL1, and chromosomal abnormalities are implicated.
• Late clonal evolution provides insights into disease predisposition.

Conclusions:

• Understanding the complex interplay of immune and genetic factors is crucial for diagnosing and treating AA.
• Advancements in genomic technologies are enhancing the understanding of AA pathogenesis.
• Improved knowledge holds the potential to significantly improve patient outcomes for aplastic anemia.